Germanmark, a leading manufacturer of labels in Spain, it has launched, together with two other companies, a pioneering system of digital authentication to end the sale of fake drugs. Is about Multibox Adfirmia, designed so that the pharmaceutical industry can protect and increase the safety of its products and that allows users to verify the authenticity of medicines. According to Iban Cid, CEO of Germark, the solution is a "great example of international business collaboration and will represent an important step forward to guarantee the safety and traceability of medicines."
Germark has developed Adfirmia Multibox, together with the firms Arjo Solutions and Cognex. Germark is responsible for the structure and all the hardware; Arjo Solutions is a French group expert in the creation of authentication and traceability systems, and Cognex is a leading American firm in industrial vision systems, which has produced the camera to take the unique image of each product.
The Adfirmia Multibox system bases its operation on “the taking, through a camera, of a special, unitary and unique image of each drug with the precision of a fingerprint”, explains Tony Valls, market director of the pharmaceutical sector at Germark . Each image corresponds to an algorithm that is stored in the database and that "allows the consumer to verify the authenticity of each product through an app and a mobile phone in real time." It does not require product marking and does not require any consumables.
The solution wants to complement the current regulations on the serialized labeling of drugs. In addition to reinforcing the protection of brands and consumers, it allows verifying the authenticity of any pharmaceutical product received over the internet or sold in geographic regions where there is still no unitary control of product monitoring. Although it is "focused on the pharmaceutical industry, it is also adaptable to sectors such as wine, cosmetics, etc.", concludes Cid.
